tiprankstipranks
Trending News
More News >
Waystar Holding Corp. (WAY)
NASDAQ:WAY
US Market
Advertisement

Waystar Holding Corp. (WAY) AI Stock Analysis

Compare
104 Followers

Top Page

WAY

Waystar Holding Corp.

(NASDAQ:WAY)

Rating:67Neutral
Price Target:
$40.00
▲(12.39%Upside)
Waystar's strong financial performance and positive earnings call sentiment are the primary strengths, supporting a solid overall score. However, the high P/E ratio and mixed technical indicators present notable risks, impacting the stock's attractiveness.
Positive Factors
Acquisition and Market Expansion
The acquisition of Iodine Software is expected to expand Waystar’s total addressable market by more than 15%.
Financial Performance
Momentum continues with record second-quarter results, indicating strong performance for Waystar Holding Corp.
Guidance and Future Growth
There is confidence in growth setup for the second half of 2025, suggesting potential for future financial improvement.
Negative Factors
Growth Moderation
The step down in growth for the second half is attributed to patient revenues declining as patients hit their deductibles.
Revenue Decline
A sequential decline in revenue is expected in the third quarter, mainly due to lower patient payment volume revenue.

Waystar Holding Corp. (WAY) vs. SPDR S&P 500 ETF (SPY)

Waystar Holding Corp. Business Overview & Revenue Model

Company DescriptionWaystar Holding Corp. is a technology company that specializes in providing revenue cycle management and healthcare payment solutions. The company operates primarily in the healthcare sector, catering to hospitals, physician practices, and other healthcare providers. Waystar's core products include software and services designed to streamline the billing and payment processes, enhance patient engagement, and ensure compliance with regulatory requirements.
How the Company Makes MoneyWaystar generates revenue through a subscription-based model, where healthcare providers pay for access to its suite of software solutions. The company offers various pricing tiers based on the size of the healthcare provider and the specific services utilized. Key revenue streams include transaction fees from payment processing, software licensing fees, and professional services for implementation and support. Additionally, Waystar has formed strategic partnerships with other technology providers and healthcare organizations to expand its market reach and enhance its product offerings, contributing significantly to its earnings.

Waystar Holding Corp. Earnings Call Summary

Earnings Call Date:Jul 30, 2025
(Q2-2025)
|
% Change Since: -0.14%|
Next Earnings Date:Nov 05, 2025
Earnings Call Sentiment Positive
The earnings call highlighted strong revenue and EBITDA growth, a significant acquisition to expand market reach, and raised financial guidance, indicating robust business momentum. Despite some regulatory uncertainties and seasonal revenue variability, the overall sentiment is positive.
Q2-2025 Updates
Positive Updates
Acquisition of Iodine Software
Waystar announced the acquisition of Iodine Software for $1.25 billion, expanding its total addressable market by more than 15% and is expected to be accretive to revenue growth and non-GAAP net income per diluted share in 2027.
Strong Revenue and EBITDA Growth
Waystar reported Q2 2025 revenue of $271 million, representing 15% year-over-year growth, with an adjusted EBITDA margin of 42%.
Raised Full Year Guidance
Waystar raised its full-year guidance for both revenue and adjusted EBITDA, citing strong performance and increased demand for its AI-powered software platform.
High Net Revenue Retention
Waystar reported a net revenue retention rate of 115% and increased the number of clients generating more than $100,000 in trailing 12-month revenue by 14% year-over-year.
Innovative AI Solutions
Waystar's AI-powered platform prevented nearly $6 billion in denied claims in the first half of 2025 and launched AltitudeAI, which boosts appeal productivity by 70%.
Negative Updates
Potential Regulatory Impact
The One Big Beautiful Bill Act and changes to Medicaid funding could impact Waystar's revenue, though the company estimates a less than 1% impact in a hypothetical scenario.
Seasonal Revenue Variability
Waystar expects revenue to decline sequentially in Q3 due to patient deductible resets and plans for Q3 and Q4 revenue to be similar on an absolute dollar basis.
Company Guidance
During the Waystar Second Quarter 2025 Earnings Call, CEO Matt Hawkins highlighted the company's strategic acquisition of Iodine Software for $1.25 billion, a move expected to expand Waystar's total addressable market by over 15%. The transaction is anticipated to be immediately accretive to gross margin and adjusted EBITDA margin and accretive to revenue growth and non-GAAP net income per diluted share by 2027. The company's Q2 2025 revenue reached $271 million, a 15% year-over-year increase, with an adjusted EBITDA margin of 42%. Waystar also raised its full-year guidance for both revenue and adjusted EBITDA, projecting revenue between $1.30 billion and $1.42 billion and an adjusted EBITDA range of $418 million to $426 million. The acquisition is expected to accelerate Waystar's product roadmap by approximately two years, enhancing automation and performance in the revenue cycle management space.

Waystar Holding Corp. Financial Statement Overview

Summary
Waystar Holding Corp. presents a strong financial position with consistent revenue growth and efficient cash flow management. The company exhibits robust operational efficiency and maintains a conservative balance sheet with low leverage. However, there is room for improvement in net profitability and return on equity to enhance overall financial performance.
Income Statement
78
Positive
Waystar Holding Corp. shows strong revenue growth with a TTM increase of 3.36% compared to the previous year. The gross profit margin is robust at 62.24%, indicating effective cost management. However, the net profit margin is low at 2.67%, suggesting room for improvement in controlling expenses or increasing revenue. The EBIT and EBITDA margins are healthy at 16.22% and 33.93% respectively, reflecting good operational efficiency.
Balance Sheet
72
Positive
The company maintains a solid equity ratio of 67.67%, showcasing financial stability. The debt-to-equity ratio is low at 0.01, reflecting minimal leverage and a conservative financial structure. Return on equity is modest at 0.83%, indicating potential for better profitability. Overall, the balance sheet is strong with low debt levels and substantial equity.
Cash Flow
85
Very Positive
Waystar demonstrates impressive free cash flow growth of 37.63%, highlighting strong cash generation capabilities. The operating cash flow to net income ratio is high at 8.56, indicating efficient conversion of income into cash. The free cash flow to net income ratio is also robust at 7.52, underscoring strong cash flow management.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue1.01B943.55M791.01M704.87M578.57M
Gross Profit680.83M627.82M541.24M306.82M250.74M
EBITDA341.34M318.93M318.58M287.50M247.66M
Net Income85.94M-19.13M-51.33M-51.45M-47.12M
Balance Sheet
Total Assets4.68B4.58B4.58B4.81B4.89B
Cash, Cash Equivalents and Short-Term Investments340.79M182.13M45.43M72.64M54.50M
Total Debt39.32M1.26B2.25B2.26B2.30B
Total Liabilities1.50B1.50B2.53B2.70B2.77B
Stockholders Equity3.17B3.08B2.05B2.11B2.12B
Cash Flow
Free Cash Flow278.56M142.50M29.94M85.20M91.86M
Operating Cash Flow304.60M169.77M51.46M102.63M106.41M
Investing Cash Flow-76.56M-27.27M-61.52M-17.43M-444.33M
Financing Cash Flow2.97M16.65M-17.15M-67.06M331.50M

Waystar Holding Corp. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price35.59
Price Trends
50DMA
38.29
Negative
100DMA
38.05
Negative
200DMA
36.75
Negative
Market Momentum
MACD
-0.83
Positive
RSI
34.37
Neutral
STOCH
34.12
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For WAY, the sentiment is Negative. The current price of 35.59 is below the 20-day moving average (MA) of 36.83, below the 50-day MA of 38.29, and below the 200-day MA of 36.75, indicating a bearish trend. The MACD of -0.83 indicates Positive momentum. The RSI at 34.37 is Neutral, neither overbought nor oversold. The STOCH value of 34.12 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for WAY.

Waystar Holding Corp. Risk Analysis

Waystar Holding Corp. disclosed 58 risk factors in its most recent earnings report. Waystar Holding Corp. reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Waystar Holding Corp. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (56)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
$7.43B14.4622.21%1.52%7.31%-15.86%
75
Outperform
$6.81B29.1824.70%15.15%34.33%
74
Outperform
$5.19B15.5121.63%1.34%3.39%-16.78%
67
Neutral
$3.54B71.4211.59%47.78%74.61%
67
Neutral
$6.20B74.712.81%17.14%
65
Neutral
$8.55B21.1111.57%4.72%-3.06%
56
Neutral
$6.50B15.33-29.08%6.35%11.10%-32.94%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
WAY
Waystar Holding Corp.
34.65
13.07
60.57%
EPAM
Epam Systems
153.30
-48.95
-24.20%
EXLS
Exlservice Holdings
42.57
9.13
27.30%
G
Genpact
42.55
10.55
32.97%
SAIC
Science Applications
113.21
-5.16
-4.36%
PAY
Paymentus Holdings
29.33
10.92
59.32%

Waystar Holding Corp. Corporate Events

M&A TransactionsBusiness Operations and Strategy
Waystar Holding Corp. Acquires Iodine Software for $1.25B
Positive
Jul 23, 2025

On July 23, 2025, Waystar Holding Corp. announced a definitive agreement to acquire Iodine Software for $1.25 billion. This acquisition is expected to enhance Waystar’s AI capabilities in healthcare payments, expand its market by over 15%, and improve its financial profile. The merger will integrate Iodine’s AI-powered clinical intelligence software, which is trusted by many health systems, to reduce administrative costs and improve revenue cycle management. The transaction is anticipated to close by the end of 2025, subject to regulatory approvals.

The most recent analyst rating on (WAY) stock is a Buy with a $42.00 price target. To see the full list of analyst forecasts on Waystar Holding Corp. stock, see the WAY Stock Forecast page.

Executive/Board ChangesShareholder Meetings
Waystar Holding Corp. Expands Board with New Directors
Neutral
Jun 5, 2025

Waystar Holding Corp. announced changes to its board of directors following its annual meeting on June 4, 2025. The board expanded from ten to twelve members, appointing Aashima Gupta and Michael Roman as independent directors. Gupta, with a background in healthcare technology, and Roman, a former CEO of 3M, bring diverse expertise to the board. Additionally, the company’s stockholders approved an amendment to the Certificate of Incorporation and re-elected three directors, while also ratifying KPMG LLP as the independent auditor for the fiscal year ending December 31, 2025.

The most recent analyst rating on (WAY) stock is a Buy with a $45.00 price target. To see the full list of analyst forecasts on Waystar Holding Corp. stock, see the WAY Stock Forecast page.

Executive/Board ChangesShareholder Meetings
Waystar Holding Corp. Expands Board with New Nominations
Neutral
May 12, 2025

On May 9, 2025, Waystar Holding Corp.‘s Board approved a grant of performance stock units to CEO Matt Hawkins, tied to the company’s shareholder return relative to the S&P SmallCap 600 Information Technology sector over a four-year period. Additionally, the company plans to expand its board from ten to twelve directors, contingent on shareholder approval to amend its Certificate of Incorporation, with Aashima Gupta and Michael Roman nominated for new director roles.

The most recent analyst rating on (WAY) stock is a Buy with a $42.0000 price target. To see the full list of analyst forecasts on Waystar Holding Corp. stock, see the WAY Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 01, 2025